國家衛生研究院 NHRI:

Sub-Community

	Winston C.Y. Yu [19/19]
	Ko-Jiunn Liu [85/98]
	Tsang-Wu Liu [119/125]
	Jieh-Yuan Liou(2003-2010) [3/3]
	Her-Shyong Shiah(1996-2012) [26/31]
	Shine-Gwo Shiah [51/54]
	Nai-Jung Chiang [82/94]
	Hui-Ju Mandy Ch'ang [39/44]
	Jang-Yang Chang [234/254]
	Kwang-Yu Chang [69/79]
	I-Shou Chang [103/106]
	Wun-Shaing Wayne Chang [52/53]
	Jeffrey Shu-Ming [89/91]
	Jacqueline Whang-Peng(1996-2007) [120/126]
	Neng-Yao Shih [37/43]
	Chia-Huei Lee [29/29]
	Alan Yueh-Luen Lee [48/49]
	Su-Fang Lin [32/32]
	Yi-Hsin Yang [41/42]
	Shih-Sheng Jiang [88/90]
	Che-Hung Shen [14/16]
	Wen-Chun Hung [88/88]
	Shuang-En Chuang [82/91]
	Kelvin Kun-Chih Tsai [32/34]
	Hui-Jen Tsai [66/71]
	Yung-Yeh Su [40/40]
	Jen-Liang Su [24/25]
	Ching-Chuan Kuo [71/76]
	Shang-Hung Chen [45/48]
	Jen-Yang Chen [72/72]
	Li-Tzong Chen [443/510]
	Mei-Shya Chen(2002-2009) [1/1]
	Shih-Cheng Chen [2/2]
	Ya-Wen Chen [38/39]
	Tze-Sing Huang [55/55]
	Dau-Yang Huang [26/26]
	Chou-Chik George Ting(2000-2004) [5/5]
	Others [464/471]
	Ming Jacqueline Liu(1996-2007) [60/62]
	Mei-Ying Liu(2004-2006) [2/2]
	Cheng-Wen Wu(1996-2008) [53/55]
	Szu-Wen Tseng(1997-2007) [4/4]
	Kuan-Te Li(1997-2004) [4/6]
	Ching-Tai Lin(1999-2007) [5/5]
	Wen-Kuang Yang(1996-1999) [21/21]
	Chuan-Cheng Wang(1996-2003) [4/4]
	Shin-Hun P. Juang(1997-2004) [11/11]
	Tzung-Huang Jan(2000-2008) [2/2]
	Gi-Ming Lai(2004-2008) [41/47]
	Li-Jung Juan(2000-2006) [6/7]
	Jim-Ray Chen(2003-2007) [6/6]
	Yen-Ying Ma(1997-1999) [1/1]
	Chi-Ying F. Huang(2005-2007) [9/10]

Siblings

	Institute of Molecular and Genomic Medicine [921/964]
	Institute of Biotechnology and Pharmaceutical Research [830/1008]
	Institute of Biomedical Engineering and Nanomedicine [1214/1334]
	Immunology Research Center [224/236]
	Center for Neuropsychiatric Research [782/804]
	Institute of Cellular and Systems Medicine [755/815]
	National Institute of Infectious Diseases and Vaccinology [1541/1618]
	Institute of Population Health Sciences [2870/3000]
	National Institute of Environmental Health Sciences [1560/1591]
	National Mosquito-Borne Diseases Control Research Center [102/104]
	National Center for Geriatrics and Welfare Research [216/224]
	Forum [2/2]
	Center of Biomedical Resource [7/7]
	NHRI Graduate Student Program [188/191]
	Core Instrument Center [9/9]
	Pathology Core Laboratory [14/14]
	Laboratory Animal Center [8/8]
	Administrative Units [18/18]

Community Statistics

	Item counts issued in 3 years:335(13.91%)
	Items With Fulltext:2250(93.40%)
Download counts of the item
	Download times greater than 0:2250(100.00%)
	Download times greater than 100:2250(100.00%)
	Total Bitstream Download Counts:1614895(30.13%)

Last Update: 2024-12-01 04:34

Top Upload

Top Download

Recent Submissions

	Pathological response following neo...
	Registry of genetic alterations of ...
	Activated single nucleotide mismatc...
	Taiwan nationwide study of first-li...
	The effectiveness of virtual passpo...
	Special Issue "Bioinformatics ...
	Evaluating a natural language proce...
	The clinicopathological significanc...
	Hypoxia in drug resistance and radi...
	DKK1 as a chemoresistant protein mo...

Jump to a point in the index:
Or type in a year:

Ordering With Most Recent First

Show Oldest First

Showing items 226-250 of 2409. (97 Page(s) Totally)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
View [10|25|50] records per page

Date	Title	Relation
2022-10-23	Real-world comparative effectiveness of nivolumab versus pembrolizumab in patients with unresectable hepatocellular carcinoma	Pharmaceutics. 2022 Oct 23;14(11):Article number 2263.
2022-10-22	Vickers hardness value test via multi-task learning convolutional neural networks and image augmentation	Applied Sciences. 2022 Oct 22;12(21):Article number 10820.
2022-10-20	Reprogramming of sentinel lymph node microenvironment during tumor metastasis	Journal of Biomedical Science. 2022 Oct 20;29:Article number 84.
2022-10-11	Upregulated ubiquitin D is a favorable prognostic indicator for rectal cancer patients undergoing preoperative concurrent chemoradiotherapy	OncoTargets and Therapy. 2022 Oct 11;15:1171-1181.
2022-10-10	Prognostic abilities of pre- and post-treatment inflammatory markers in oral squamous cell carcinoma: Stepwise modelling	Medicina. 2022 Oct 10;58(10):Article number 1426.
2022-10	Chronic mechanical irritation enhances the effect of tobacco and alcohol on the risk of oral squamous cell carcinoma: A case-control study in Argentina	Clinical Oral Investigations. 2022 Oct;26(10):6317-6326.
2022-10	The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma	Hepatology International. 2022 Oct;16(5):1137-1149.
2022-10	Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study	Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-10	Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression	Hepatology. 2022 Oct;76(Suppl.1):S1411-S1412.
2022-10	An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis	MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2022 Oct:229-230.
2022-09-26	Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?	Journal of Biomedical Science. 2022 Sep 26;29:Article number 74.
2022-09-21	Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer	International Journal of Medical Sciences. 2022 Sep 21;19(10):1615-1627.
2022-09-15	Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin	American Journal of Cancer Research. 2022 Sep 15;12(9):4267-4278.
2022-09-13	UMOD mutations in chronic kidney disease in Taiwan	Biomedicines. 2022 Sep 13;10(9):Article number 2265.
2022-09	Beta-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral cancer patients	Oral Diseases. 2022 Sep;28(6):1484-149.
2022-09	Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease	Journal of the Formosan Medical Association. 2022 Sep;121(9):1705-1713.
2022-09	Multi-kinase inhibitors for the treatment of asymptomatic radioactive Iodine-refractory differentiated thyroid cancer: Global non-interventional study (RIFTOS MKI)	Thyroid. 2022 Sep;32(9):1059-1068.
2022-09	A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study	European Journal of Cancer. 2022 Sep;173:123-132.
2022-09	High MT2A expression predicts worse prognosis in patients with urothelial carcinoma	Oncology. 2022 Sep;100(9):485-497.
2022-09	Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan	Liver Cancer. 2022 Sep;11(5):426-439.
2022-09	Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)	Annals of Oncology. 2022 Sep;33(7):S565-S566.
2022-08-28	Injectability, processability, drug loading, and antibacterial activity of gentamicin-impregnated mesoporous bioactive glass composite calcium phosphate bone cement in vitro	Biomimetics. 2022 Aug 28;7(3):Article number 121.
2022-08-07	Selenium yeast and fish oil combination diminishes cancer stem cell traits and reverses cisplatin resistance in A549 sphere cells	Nutrients. 2022 Aug 7;14(15):Article number 3232.
2022-08	STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo	Anticancer Research. 2022 Aug;42(8):3807-3814.
2022-08	IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis	Cell and Bioscience. 2022 Aug;12:Article number 124.